URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Leonor Rivera-Calimlim

TitleProfessor Emeritus
InstitutionSchool of Medicine and Dentistry
DepartmentPharmacology and Physiology
Address
 
 Selected Publications
List All   |   Timeline
  1. Newland MC, Rivera-Calimlim L, Weiss B. Interactions between ethanol and pantothenic acid on tremor and behavior in squirrel monkeys. J Stud Alcohol. 1992 Jan; 53(1):80-5.
    View in: PubMed
  2. Rivera-Calimlim L, Hartley D, Osterhout D. Effects of ethanol and pantothenic acid on brain acetylcholine synthesis. Br J Pharmacol. 1988 Sep; 95(1):77-82.
    View in: PubMed
  3. Rivera-Calimlim L. The significance of drugs in breast milk. Pharmacokinetic considerations. Clin Perinatol. 1987 Mar; 14(1):51-70.
    View in: PubMed
  4. Kurlan R, Rubin AJ, Miller C, Rivera-Calimlim L, Clarke A, Shoulson I. Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations. Ann Neurol. 1986 Aug; 20(2):262-5.
    View in: PubMed
  5. Rivera-Calimlim L, Calimlim JF, Liang R, Lasagna L, Diamond GL. Bioavailability and pharmacological effects of two slow-release theophylline preparations: intrasubject tablet-to-tablet variability. J Asthma. 1986; 23(3):113-22.
    View in: PubMed
  6. Rivera-Calimlim L, Reilly DK. Difference in erythrocyte catechol-O-methyltransferase activity between Orientals and Caucasians: difference in levodopa tolerance. Clin Pharmacol Ther. 1984 Jun; 35(6):804-9.
    View in: PubMed
  7. Rivera-Calimlim L, Hershey L. Neuroleptic concentrations and clinical response. Annu Rev Pharmacol Toxicol. 1984; 24:361-86.
    View in: PubMed
  8. Reilly DK, Hershey L, Rivera-Calimlim L, Shoulson I. On-off effects in Parkinson's disease: a controlled investigation of ascorbic acid therapy. Adv Neurol. 1983; 37:51-60.
    View in: PubMed
  9. Rivera-Calimlim L. Problems in therapeutic blood monitoring of chlorpromazine. Ther Drug Monit. 1982; 4(1):41-9.
    View in: PubMed
  10. Hershey LA, Gift T, Atkins RW, Rivera-Calimlim L. Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients. Psychopharmacology (Berl). 1981; 73(4):355-8.
    View in: PubMed
  11. Reilly DK, Rivera-Calimlim L, Van Dyke D. Catechol-O-methyltransferase activity: a determinant of levodopa response. Clin Pharmacol Ther. 1980 Aug; 28(2):278-86.
    View in: PubMed
  12. Rivera-Calimlim L, Griesbach PH, Perlmutter R. Plasma chlorpromazine concentrations in children with behavioral disorders and mental illness. Clin Pharmacol Ther. 1979 Jul; 26(1):114-21.
    View in: PubMed
  13. Rivera-Calimlim L, Bosmann HB, Penney DP, Karch FE. Biochemical, morphologic and physiologic changes in the adrenal glands of rats chronically treated with phenobarbital. Res Commun Chem Pathol Pharmacol. 1978 Jul; 21(1):1-14.
    View in: PubMed
  14. Rivera-Calimlim L, Kerzner B, Karch FE. Effect of lithium on plasma chlorpromazine levels. Clin Pharmacol Ther. 1978 Apr; 23(4):451-5.
    View in: PubMed
  15. Rivera-Calimlim L, Gift T, Nasrallah HA, Wyatt RJ, Lasagna L. Correlation between plasma concentrations of chlorpromazine and clinical response. Commun Psychopharmacol. 1978; 2(3):215-22.
    View in: PubMed
  16. Sundaresan PR, Rivera-Calimlim L. Mechanism of chlorpromazine action on rat intestinal transport processes. Biochem Pharmacol. 1978; 27(24):2781-6.
    View in: PubMed
  17. Rivera-calimlim L. Drugs in breast milk. Drug Ther (NY). 1977 Dec; 7(12):59-63.
    View in: PubMed
  18. Sundaresan PR, Rivera-Calimlim L. Effect of chlorpromazine on L-methionine transport in the rat intestine. Biochem Pharmacol. 1977 Aug 1; 26(15):1411-5.
    View in: PubMed
  19. Nasrallah HA, Donnelly EF, Bigelow LB, Rivera-Calimlim L, Rogol A, Potkin S, Rauscher FP, Wyatt RJ. Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosine. Arch Gen Psychiatry. 1977 Jun; 34(6):649-55.
    View in: PubMed
  20. Rivera-Calimlim L. The pharmacology and therapeutic application of the phenothiazines. Ration Drug Ther. 1977 Apr; 11(4):1-8.
    View in: PubMed
  21. Rivera-Calimlim L, Tandon D, Anderson F, Joynt R. The clinical picture and plasma levodopa metabolite profile of parkinsonian nonresponders. Treatment with levodopa and decarboxylase inhibitor. Arch Neurol. 1977 Apr; 34(4):228-32.
    View in: PubMed
  22. Rivera-Calimlim L, Siracusa A. Plasma assay of fluphenazine. Commun Psychopharmacol. 1977; 1(3):233-42.
    View in: PubMed
  23. Rivera-Calimlim L, Nasrallah H, Strauss J, Lasagna L. Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels. Am J Psychiatry. 1976 Jun; 133(6):646-52.
    View in: PubMed
  24. Rivera-Calimlim L. Impaired absorption of chlorpromazine in rats given trihexyphenidyl. Br J Pharmacol. 1976 Mar; 56(3):301-5.
    View in: PubMed
  25. Rivera-Calimlim L. Effect of lithium on gastric emptying and absorption of oral chlorpromazine. Psychopharmacol Commun. 1976; 2(3):263-72.
    View in: PubMed
  26. Morgan JP, Rivera-Calimlim L, Messiha F, Sundaresan PR, Trabert N. Imipramine-mediated interference with levodopa absorption from the gastrointestinal tract in man. Neurology. 1975 Nov; 25(11):1029-34.
    View in: PubMed
  27. Sundaresan PR, Rivera-Calimlim L. Distribution of chlorpromazine in the gastrointestinal tract of the rat and its effect on absorptive function. J Pharmacol Exp Ther. 1975 Sep; 194(3):593-602.
    View in: PubMed
  28. Rivera-Calimlim L, Bosmann HB, Penney DP, Lasagna L. Lysosomal changes in the gut of rats after chronic treatment with phenobarbital. Biochem Pharmacol. 1975 Jun 15; 24(11-12):1161-6.
    View in: PubMed
  29. Joubert P, Rivera-Calimlim L, Lasagna L. Commentary. The normal volunteer in clinical investigation: how rigid should selection criteria be? Clin Pharmacol Ther. 1975 Mar; 17(3):253-7.
    View in: PubMed
  30. Morgan JP, Nathan G, Rivera-Calimlim L, Trabert N. Imipramine-caused interference with levodopa absorption from the gastrointestinal tract in rats. J Pharmacol Exp Ther. 1975 Feb; 192(2):451-7.
    View in: PubMed
  31. Rivera-Calimlim L. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats. Br J Pharmacol. 1974 Feb; 50(2):259-63.
    View in: PubMed
  32. Rivera-Calimlim L, CastaƱeda L, Lasagna L. Effects of mode of management on plasma chlorpromazine in psychiatric patients. Clin Pharmacol Ther. 1973 Nov-Dec; 14(6):978-86.
    View in: PubMed
  33. Rivera-Calimlim L, Bosmann HB, Penney DP, Lasagna L. Morphologic and biochemical changes in the gut after chronic treatment with L-dopa. J Pharmacol Exp Ther. 1973 Feb; 184(2):440-8.
    View in: PubMed
  34. Rivera-Calimlim L. Effect of chronic drug treatment on intestinal membrane transport of 14 C-L-dopa. Br J Pharmacol. 1972 Dec; 46(4):708-13.
    View in: PubMed
  35. Rivera-Calimlim L, Bianchine JR. Effect of L-dopa on plasma free fatty acids and plasma glucose. Metabolism. 1972 Jul; 21(7):611-7.
    View in: PubMed
  36. Rivera-Calimlim L, Morgan JP, Dujovne CA, Bianchine JR, Lasagna L. L-3,4-dihydroxyphenylalanine metabolism by the gut in vitro. Biochem Pharmacol. 1971 Nov; 20(11):3051-7.
    View in: PubMed
  37. Morgan JP, Bianchine JR, Spiegel HE, Rivera-Calimlim L, Hersey RM. Metabolism of levodopa in patients with Parkinson's disease. Radioactive and fluorometric assays. Arch Neurol. 1971 Jul; 25(1):39-44.
    View in: PubMed
  38. Rivera-Calimlim L, Dujovne CA, Morgan JP, Lasagna L, Bianchine JR. Absorption and metabolism of L-dopa by the human stomach. Eur J Clin Invest. 1971 May; 1(5):313-20.
    View in: PubMed
  39. Rivera-Calimlim L, Dujovne CA, Morgan JP, Lasagna L, Bianchine JR. L-dopa treatment failure: explanation and correction. Br Med J. 1970 Oct 10; 4(5727):93-4.
    View in: PubMed
  40. Wright PH, Rivera-Calimlim L, Malaisse WJ. Endogenous insulin secretion in the rat following injection of anti-insulin serum. Am J Physiol. 1966 Nov; 211(5):1089-94.
    View in: PubMed
  41. Wright PH, Rivera-Calimlim L. Assay of insulin antibodies produced by the guinea-pig. Nature. 1965 Aug 28; 207(5000):995-6.
    View in: PubMed

Visualizations


Rivera-Calimlim's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department